Seminar „Experimentelle Tumorforschung“
Donnerstag 15.30 - 16.30 Uhr
Veranstaltungsort: Seminarraum im 3. OG, Raum 317, Institut für Experimentelle Tumorforschung
| Datum | Titel | Referent/in |
|---|---|---|
| 24.10.2019 | Introduction into research of the group Inflammatory Carcinogenesis | Susanne Sebens |
| 31.10.2019 | Reformationstag > no seminar |
|
| 07.11.2019 | Role of PD-L1 in the tumor stroma interplay in pancreatic cancer | Tina Daunke |
| 14.11.2019 | Generation of anti-FP3-Elafin drug conjugate for targeted inhibition of neutrophil elastase activity | Farhad Haj Mohamad |
| 21.11.2019 | KLS-Retreat > no seminar | |
| 28.11.2019 | A third dimension is necessary for a realistic imitation of in vivo tumors: The role of ADAM17 in chemo-resistance of ovarian cancer | Andreas Herz |
| 05.12.2019 | Regulation of PD-L1 expression in pancreatic cancer cells by insulin | Franziska Mau |
| 12.12.2019 | The pleiotropiccytokineTRAIL-functionsofsoluble andmembrane-boundform | Mouhamad Khouja |
| 19.12.2019 |
Role of TRAIL-R4 in apoptotic and non-apoptotic signaling in pancreatic cancer |
Sebastian Weiße |
| 09.01.2020 | Internship Report |
Kira Bickenbach |
| 16.01.2020 | MCT1 lactate carrier expression in ovarian cancer cells - a suitable marker of chemoresistance and malignancy | Nele Kunert |
| 23.01.2020 | Internship Report | Per Arkenberg |
| 30.01.2020 | Antigen loaded nanoparticles as tumor vaccination strategy |
Silje Beckinger |